
Espero Life Sciences Private Limited
About Espero Life Sciences Private Limited
Data last updated:
Espero Life Sciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 05 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2018PTC330316. Its GSTIN is 10AAECE9562G1ZS (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rikta Chatterjee and Sarika Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No.D – 555 Gali No. – 63 Mahabir Enclave – III, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.27 Lakh, a decline of 20% compared to the previous year. For the same year it recorded a net profit of ₹9,461 (net margin 0.5%) and EBITDA of ₹26,131 (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 2% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Espero Life Sciences Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressH No.D – 555 Gali No. – 63 Mahabir Enclave – III, New Delhi, Delhi, India – 110059
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
To see the full contact details of Espero Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Espero Life Sciences is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Espero Life Sciences Private Limited, buy the company report.
Financials of Espero Life Sciences Private Limited
FY 2025 filings availableEspero Life Sciences Private Limited reported revenue of ₹18.27 Lakh (down 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 20% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 2%. EBITDA fell 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹26,131 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹9,461 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Espero Life Sciences Private Limited, buy the company report.
Board of directors of Espero Life Sciences Private Limited
Espero Life Sciences has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rikta Chatterjee | Director | 05 Mar 2018 | 8 Years 8 Months | Current |
| Sarika Kumari | Director | 05 Mar 2018 | 8 Years 8 Months | Current |
| Arti Kumari | Additional Director | 10 May 2019 | 7 Years 6 Months | Current |
| Arbind Kumar Jha | Director | 05 Mar 2018 | 8 Years 8 Months | Current |
Peer comparison
Espero Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (human health activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Docto New Life Polyclinic Private Limited | ₹18.39 Lakh (FY 2025) | 453.0% | Noida, Uttar Pradesh, India | |||
| Prakash Healthcare Private Limited | ₹18.36 Lakh (FY 2025) | 7.0% | New Delhi, Delhi, India | |||
| Shammed Healthcare and Research (OPC) Private Limited | ₹18.3 Lakh (FY 2025) | 11.0% | Tdi, Kundli Sonipat, Haryana, India | |||
| SGBR Healthcare Private Limited | ₹18.3 Lakh (FY 2025) | 1.0% | Delhi, India | |||
| Prospera Health Centre Private Limited | ₹18.29 Lakh (FY 2024) | Bhoranj, Himachal Pradesh, India | ||||
| Espero Life Sciences Private Limitedthis company | ₹18.27 Lakh (FY 2025) | ₹9,461 | 0.5% | -20.0% | New Delhi, Delhi, India | |
| Friends Diagnostic Private Limited | ₹18.25 Lakh (FY 2025) | 0.0% | Kolkata, West Bengal, India | |||
| Orio Fitness Studio & Health Care Private Limited | ₹18.24 Lakh (FY 2025) | 74.0% | Salem, Tamil Nadu, India | |||
| Doctek Innovation Private Limited | ₹18.2 Lakh (FY 2025) | 366.0% | Bangalore, Karnataka, India | |||
| Net4meds Private Limited | ₹18.14 Lakh (FY 2025) | 1410.0% | Delhi, India | |||
| Pur Health Online Services Private Limited | ₹18.09 Lakh (FY 2025) | 29.0% | Saluru, Andhra Pradesh, India |
To see the full peer comparison of Espero Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Espero Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Espero Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Espero Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECE9562G1ZS | Bihar | Active | 01 Aug 2018 |
To see the full GST registrations and return filing status of Espero Life Sciences Private Limited, buy the company report.
Recent activity
Espero Life Sciences Private Limited has 5 board changes on record since 2018: 4 appointments and 1 cessation. The latest: Abhijeet Kumar Chaudhary ceased to be Director on 12 Jun 2020.
Frequently asked questions
Espero Life Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 05 March 2018 (8+ years old) and is registered under CIN U24304DL2018PTC330316.
Espero Life Sciences has 4 current directors:
- Rikta Chatterjee - Director
- Sarika Kumari - Director
- Arti Kumari - Additional Director
- Arbind Kumar Jha - Director
The latest financial statements of Espero Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Espero Life Sciences is 10AAECE9562G1ZS, registered in Bihar.
The CIN (Corporate Identification Number) of Espero Life Sciences is U24304DL2018PTC330316. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Espero Life Sciences was incorporated on 05 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Espero Life Sciences by revenue are Docto New Life Polyclinic Private Limited, Prakash Healthcare Private Limited, Shammed Healthcare and Research (OPC) Private Limited, SGBR Healthcare Private Limited, Prospera Health Centre Private Limited and 5 more, all in the same principal business activity (human health activities).
Abhijeet Kumar Chaudhary ceased to be Director on 12 Jun 2020. Arti Kumari was appointed as Additional Director on 10 May 2019. Arbind Kumar Jha was appointed as Director on 05 Mar 2018. Espero Life Sciences has 5 board changes on record in total.
The registered office of Espero Life Sciences is at H No.D – 555 Gali No. – 63 Mahabir Enclave – III, New Delhi, Delhi, India – 110059.
Espero Life Sciences operates in the food and beverages industry, in the artificial fibres segment.
The compliance status of Espero Life Sciences is compliant as of 23 August 2026. The company is actively filing with the Registrar of Companies.

